{
  "id": "3ce74537d1dec169811db57ec73381590ceb9859",
  "title": "Ozempic may offer a surprising bonus benefit for brain health",
  "summary": "A new analysis suggests that people with type 2 diabetes who use GLP-1 medications like Ozempic, Trulicity or Victoza may be less likely to develop epilepsy than those taking DPP-4 inhibitors. Semaglutide showed the strongest connection to lowered risk. Researchers caution that the findings show an association, not proof of cause and effect. More rigorous lâ€¦",
  "canonicalUrl": "https://www.sciencedaily.com/releases/2025/12/251213042249.htm",
  "source": {
    "id": "sciencedaily_health",
    "name": "ScienceDaily - Health & Medicine",
    "url": "https://www.sciencedaily.com/news/health_medicine/",
    "feedUrl": "https://www.sciencedaily.com/rss/health_medicine.xml",
    "country": "US",
    "language": "en"
  },
  "publishedAt": "2025-12-13T13:52:34.000Z",
  "fetchedAt": "2025-12-24T00:05:47.561Z",
  "category": "health",
  "tags": [],
  "image": null,
  "language": "en",
  "storagePath": "data/articles/health/2025/12/13/3ce74537d1dec169811db57ec73381590ceb9859.json"
}
